Genève, Switzerland

Shaheen Ahmed


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Location History:

  • Zurich, CH (2014)
  • Genève, CH (2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shaheen Ahmed: Innovator in Cancer Treatment

Introduction

Shaheen Ahmed is a prominent inventor based in Genève, Switzerland. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. With a total of 2 patents, her work focuses on targeting specific oncogenic proteins to combat cancer effectively.

Latest Patents

Shaheen Ahmed's latest patents include groundbreaking inventions aimed at treating cancer. One of her notable patents is for "Alpha-carbolines for the treatment of cancer." This invention relates to inhibitors of the oncogenic protein kinase ALK, which are described by a specific formula. These compounds are essential in preparing medicaments for cancer treatment. Another significant patent is for "Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl," which also involves compounds of a specific formula aimed at inhibiting these oncogenic proteins.

Career Highlights

Throughout her career, Shaheen Ahmed has worked with esteemed institutions such as Università degli Studi di Milano-Bicocca and Université de Genève. Her research has been pivotal in advancing the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes through innovative solutions.

Collaborations

Shaheen has collaborated with notable colleagues, including Luca Mologni and Leonardo Scapozza. These partnerships have enriched her research and contributed to the successful development of her patented inventions.

Conclusion

Shaheen Ahmed stands out as a dedicated inventor in the field of cancer treatment, with her innovative patents paving the way for new therapeutic options. Her work exemplifies the impact of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…